Jean Boulle Group

Jean Boulle Group is a diversified global investment firm with a prominent healthcare division, Jean Boulle Medtech, focused on developing transformative medical technologies. The group acts as an incubator and long-term partner for innovative companies, particularly in the cardiology and diabetes sectors. Its portfolio includes high-impact ventures such as Tandem Diabetes Care, which revolutionized insulin pump therapy, and V-Wave, a developer of interatrial shunts for heart failure patients. By providing capital and strategic guidance, Jean Boulle Group facilitates the transition of medical breakthroughs from early-stage research to global commercialization. The group's approach combines deep sector expertise with a commitment to improving patient outcomes through disruptive innovation.